{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:54:48Z","timestamp":1771523688082,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcomas in children. This study aimed to investigate the prognostic factors of pelvic and genitourinary RMS in children and evaluate the survival outcomes of these children treated with or without radiation therapy (RT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Surveillance, Epidemiology, and End Results Program (SEER) database was required for children with pelvic and genitourinary RMS. Overall survival (OS) and cancer-specific survival (CSS) were analyzed using the Kaplan-Meier method, log-rank test, Cox proportional hazards models, and propensity score-matched analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For the 262 patients analyzed, the most common biological subtypes were embryonic (n=209, 79.8%) and alveolar (n=29, 11.1%). Patients with alveolar RMS had the worst prognosis (P &amp;lt; 0.05). The testis (n=122, 46.6%) was the most common location, followed by the urinary bladder (n=57, 21.8%) and prostate (n=48, 18.3%). Uterus RMS had the highest survival rate, followed by testis, urinary bladder, and prostate RMS. Favorable prognostic factors were age at diagnosis &amp;lt; 15 years, non-alveolar histological subtype, early tumor stage (localized\/regional), specific sites (uterus and testis), and treatment (cancer-directed surgery and chemotherapy) (P &amp;lt; 0.05). Propensity score-matched analyses comparing the cohorts of patients treated with or without RT demonstrated no significant differences in prognostic survival (OS: P=0.872, CSS: P=0.713).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The nomogram constructed based on independent prognostic factors may accurately predict survival rates at 1 and 5 years. Surgery and adjuvant chemotherapy can be effective treatments, but RT fails to guarantee a survival benefit. Therefore, prospective trials evaluating RT for pediatric pelvic and genitourinary RMS are warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.992738","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:15:26Z","timestamp":1662354926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors of pediatric pelvic and genitourinary rhabdomyosarcoma: An analysis based on SEER database"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.12.025","article-title":"Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric soft tissue sarcoma study group RMS2005 experience","volume":"146","author":"Bergeron","year":"2021","journal-title":"Eur J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1285-0","article-title":"Focusing on organ preservation and function: Paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma","volume":"48","author":"Shapiro","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1580629","article-title":"Genitourinary considerations in reoperative and complex colorectal surgery","volume":"29","author":"Althumairi","year":"2016","journal-title":"Clin Colon Rectal Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20310","article-title":"Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study","volume":"44","author":"Punyko","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.4.614","article-title":"Late effects of therapy in patients with paratesticular rhabdomyosarcoma. intergroup rhabdomyosarcoma study committee","volume":"10","author":"Heyn","year":"1992","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.01.011","article-title":"Efficacy and safety of limited-margin conformal radiation therapy for pediatric rhabdomyosarcoma: Long-term results of a phase 2 study","volume":"107","author":"Tinkle","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.0501","article-title":"Practical guide to surgical data sets: Surveillance, epidemiology, and end results (SEER) database","volume":"153","author":"Doll","year":"2018","journal-title":"JAMA surg."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"B9","article-title":"rms: Regression modeling strategies","volume-title":"R package version 5.1-4","author":"FE","year":""},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-014-9908-2","article-title":"Survival analysis and regression models","volume":"21","author":"George","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.130","article-title":"Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the international society of paediatric oncology\u2013SIOP malignant mesenchymal tumor 89","volume":"23","author":"Stevens","year":"2005","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.22451.1","article-title":"Recent advances in understanding and managing pediatric rhabdomyosarcoma","volume":"9","author":"Gartrell","year":"2020","journal-title":"F1000"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.018788","article-title":"Survival with persistent metastatic alveolar rhabdomyosarcoma","volume":"13","author":"Louie","year":"2017","journal-title":"J Oncol Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmhimx.2016.09.001","article-title":"Alveolar rhabdomyosarcoma: Origin and prognostic implications of molecular findings","volume":"73","author":"Egu\u00eda-Aguilar","year":"2016","journal-title":"Boletin medico del Hosp Infantil Mexico"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11285","article-title":"Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: A report from the Italian and German soft tissue cooperative groups studies","volume":"97","author":"Cecchetto","year":"2003","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20012","article-title":"Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study-IV, 1991-1997","volume":"42","author":"Raney","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.7207","article-title":"Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from united states and European cooperative groups","volume":"26","author":"Oberlin","year":"2008","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/AHMT.S44582","article-title":"Rhabdomyosarcoma in adolescent and young adult patients: Current perspectives","volume":"5","author":"Egas-Bejar","year":"2014","journal-title":"Adolesc health Med Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1302\/2058-5241.5.200069","article-title":"Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis - a systematic literature review","volume":"5","author":"Smolle","year":"2020","journal-title":"EFORT Open Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyab120","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma: JCOG bone and soft tissue tumor study group","volume":"51","author":"Hiraga","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70346-7","article-title":"Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): A multicentre randomised controlled trial","volume":"13","author":"Woll","year":"2012","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27096","article-title":"Localized vaginal\/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups","volume":"65","author":"Minard-Colin","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.07.064","article-title":"Late effects in 164 patients with rhabdomyosarcoma of the bladder\/prostate region: A report from the international workshop","volume":"176","author":"Raney","year":"2006","journal-title":"J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2021.07.001","article-title":"Four ways to decrease late toxicity from pelvic radiation therapy in children and young adults","volume":"11","author":"Blitzer","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26061","article-title":"Late toxicities of intensity-modulated radiation therapy for head and neck rhabdomyosarcoma","volume":"63","author":"Lockney","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.2.262","article-title":"Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup rhabdomyosarcoma study committee","volume":"11","author":"Heyn","year":"1993","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.024","article-title":"The effects of external beam irradiation on the growth of flat bones in children: Modeling a dose-volume effect","volume":"62","author":"Krasin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.07.1989","article-title":"Proton radiotherapy for pediatric bladder\/prostate rhabdomyosarcoma: Clinical outcomes and dosimetry compared to intensity-modulated radiation therapy","volume":"81","author":"Cotter","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.4469","article-title":"Results of the intergroup rhabdomyosarcoma study group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group","volume":"29","author":"Raney","year":"2011","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pbc.22928","article-title":"Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group","volume":"57","author":"Walterhouse","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"B33","unstructured":""},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients","volume":"27","author":"Sultan","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.992738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:15:31Z","timestamp":1662354931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.992738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":34,"alternative-id":["10.3389\/fonc.2022.992738"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.992738","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"992738"}}